Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients

作者: Paola Filipazzi , Veronica Huber , Licia Rivoltini

DOI: 10.1007/S00262-011-1161-9

关键词: Immune systemMyeloid-derived Suppressor CellImmunotherapyBiologyImmunologyTumor microenvironmentPopulationCancer researchMyeloidCellular differentiationTumor Escape

摘要: The involvement of a smouldering microenvironment is currently considered cancer hallmark and required step for tumour cells to disable specific immunity while promoting angiogenesis stroma remodelling. Nevertheless, the molecular pathways driving such aberrant interactions in human their actual implication disease progression are still poorly defined. Here, we will report about remarkable efforts devoted by our group as well many other scientists dissect this process focusing on tumour-mediated activation myeloid dysfunctional occurring patients. Indeed, myeloid-derived suppressor (MDSC), playing crucial role cellular regulators immune responses, have been extensively shown restrain through vast array mechanisms promote different murine models. Although mice phenotypic features these were defined initially rather generally Gr1+ CD11b+ co-expression, more recent studies unravelled complexity population existence cell subsets. This even remarked setting, where heterogeneous populations with variable phenotype immunosuppressive described patients affected types tumours. lack homogeneous properties MDSC has made controversial unacknowledged player cancer-related suppression progression. scientific community, soon reveal key thereby becoming novel targets innovative therapeutic strategies.

参考文章(56)
M. K. Brimnes, A. J. Vangsted, L. M. Knudsen, P. Gimsing, A. O. Gang, H. E. Johnsen, I. M. Svane, Increased Level of both CD4+FOXP3+ Regulatory T Cells and CD14+HLA‐DR−/low Myeloid‐Derived Suppressor Cells and Decreased Level of Dendritic Cells in Patients with Multiple Myeloma Scandinavian Journal of Immunology. ,vol. 72, pp. 540- 547 ,(2010) , 10.1111/J.1365-3083.2010.02463.X
Sergei Kusmartsev, Yulia Nefedova, Daniel Yoder, Dmitry I. Gabrilovich, Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. Journal of Immunology. ,vol. 172, pp. 989- 999 ,(2004) , 10.4049/JIMMUNOL.172.2.989
Bond Almand, Joseph I. Clark, Ekaterina Nikitina, James van Beynen, Nicholas R. English, Stella C. Knight, David P. Carbone, Dmitry I. Gabrilovich, Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. Journal of Immunology. ,vol. 166, pp. 678- 689 ,(2001) , 10.4049/JIMMUNOL.166.1.678
Susanna Mandruzzato, Samantha Solito, Erika Falisi, Samuela Francescato, Vanna Chiarion-Sileni, Simone Mocellin, Antonio Zanon, Carlo R. Rossi, Donato Nitti, Vincenzo Bronte, Paola Zanovello, IL4Rα+ Myeloid-Derived Suppressor Cell Expansion in Cancer Patients Journal of Immunology. ,vol. 182, pp. 6562- 6568 ,(2009) , 10.4049/JIMMUNOL.0803831
Sergei Kusmartsev, Evgeniy Eruslanov, Hubert Kübler, Timothy Tseng, Yoshihisa Sakai, Zhen Su, Sergei Kaliberov, Axel Heiser, Charles Rosser, Philip Dahm, Dietmar Siemann, Johannes Vieweg, Oxidative Stress Regulates Expression of VEGFR1 in Myeloid Cells: Link to Tumor-Induced Immune Suppression in Renal Cell Carcinoma Journal of Immunology. ,vol. 181, pp. 346- 353 ,(2008) , 10.4049/JIMMUNOL.181.1.346
Je-In Youn, Srinivas Nagaraj, Michelle Collazo, Dmitry I. Gabrilovich, Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice Journal of Immunology. ,vol. 181, pp. 5791- 5802 ,(2008) , 10.4049/JIMMUNOL.181.8.5791
Anne-Sophie Dugast, Thomas Haudebourg, Flora Coulon, Michèle Heslan, Fabienne Haspot, Nicolas Poirier, Romain Vuillefroy de Silly, Claire Usal, Helga Smit, Bernard Martinet, Pamela Thebault, Karine Renaudin, Bernard Vanhove, Myeloid-Derived Suppressor Cells Accumulate in Kidney Allograft Tolerance and Specifically Suppress Effector T Cell Expansion Journal of Immunology. ,vol. 180, pp. 7898- 7906 ,(2008) , 10.4049/JIMMUNOL.180.12.7898
Tim F. Greten, Michael P. Manns, Firouzeh Korangy, Myeloid derived suppressor cells in human diseases International Immunopharmacology. ,vol. 11, pp. 802- 807 ,(2011) , 10.1016/J.INTIMP.2011.01.003
Minu K. Srivastava, Jacobus J. Bosch, James A. Thompson, Bruce R. Ksander, Martin J. Edelman, Suzanne Ostrand-Rosenberg, Lung cancer patients’ CD4+ T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells Cancer Immunology, Immunotherapy. ,vol. 57, pp. 1493- 1504 ,(2008) , 10.1007/S00262-008-0490-9
Clotilde Théry, Matias Ostrowski, Elodie Segura, Membrane vesicles as conveyors of immune responses Nature Reviews Immunology. ,vol. 9, pp. 581- 593 ,(2009) , 10.1038/NRI2567